"Liver Cirrhosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
Descriptor ID |
D008103
|
MeSH Number(s) |
C06.552.630
|
Concept/Terms |
Liver Cirrhosis- Liver Cirrhosis
- Cirrhosis, Liver
- Cirrhoses, Liver
- Liver Cirrhoses
- Hepatic Cirrhosis
- Cirrhoses, Hepatic
- Cirrhosis, Hepatic
- Hepatic Cirrhoses
|
Below are MeSH descriptors whose meaning is more general than "Liver Cirrhosis".
Below are MeSH descriptors whose meaning is more specific than "Liver Cirrhosis".
This graph shows the total number of publications written about "Liver Cirrhosis" by people in this website by year, and whether "Liver Cirrhosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1995 | 1 | 1 | 2 |
1996 | 2 | 0 | 2 |
1997 | 1 | 4 | 5 |
1998 | 4 | 1 | 5 |
1999 | 0 | 3 | 3 |
2000 | 3 | 2 | 5 |
2001 | 2 | 1 | 3 |
2002 | 2 | 4 | 6 |
2003 | 3 | 3 | 6 |
2004 | 0 | 2 | 2 |
2005 | 3 | 1 | 4 |
2006 | 5 | 3 | 8 |
2007 | 3 | 2 | 5 |
2008 | 6 | 1 | 7 |
2009 | 6 | 4 | 10 |
2010 | 6 | 1 | 7 |
2011 | 6 | 2 | 8 |
2012 | 5 | 3 | 8 |
2013 | 5 | 2 | 7 |
2014 | 7 | 2 | 9 |
2015 | 10 | 4 | 14 |
2016 | 16 | 3 | 19 |
2017 | 10 | 5 | 15 |
2018 | 9 | 3 | 12 |
2019 | 12 | 2 | 14 |
2020 | 4 | 8 | 12 |
2021 | 3 | 14 | 17 |
2022 | 1 | 9 | 10 |
2023 | 0 | 10 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Liver Cirrhosis" by people in Profiles.
-
Natural history of NASH cirrhosis in liver transplant waitlist registrants. J Hepatol. 2023 10; 79(4):1015-1024.
-
Non-Alcoholic Fatty Liver Disease: Translating Disease Mechanisms into Therapeutics Using Animal Models. Int J Mol Sci. 2023 Jun 10; 24(12).
-
Clinical characteristics and management of patients with nonalcoholic steatohepatitis in a real-world setting: analysis of the Ipsos NASH therapy monitor database. BMC Gastroenterol. 2023 May 19; 23(1):160.
-
Transjugular Intrahepatic Portosystemic Shunt Placement: Entering the Era of Controlled Expansion. Cardiovasc Intervent Radiol. 2023 06; 46(6):823-824.
-
Change in Platelet Count after Transjugular Intrahepatic Portosystemic Shunt Creation: An Advancing Liver Therapeutic Approaches (ALTA) Group Study. J Vasc Interv Radiol. 2023 08; 34(8):1364-1371.
-
Liver Transplantation 2023: Status Report, Current and Future Challenges. Clin Gastroenterol Hepatol. 2023 Jul; 21(8):2150-2166.
-
Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies. Oncologist. 2023 04 06; 28(4):341-350.
-
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023 05 01; 77(5):1797-1835.
-
Recall patterns and risk of primary liver cancer for subcentimeter ultrasound liver observations: a multicenter study. Hepatol Commun. 2023 03 01; 7(3).
-
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Nonhepatocellular Cancers. Clin Liver Dis. 2023 05; 27(2):251-273.